{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:17:40Z","timestamp":1745986660188,"version":"3.40.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Cystic Fibrosis Society Patient Registry"},{"DOI":"10.13039\/100012996","name":"University of Cyprus","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The high variety of mutations found in the Cystic Fibrosis Transmembrane Regulator (<jats:italic>CFTR<\/jats:italic>) gene is responsible for the clinical heterogeneity observed in people with Cystic Fibrosis (CF) and the atypical manifestations in CFTR-related disorders (CFTR-RD). The intronic c.489+3A&gt;G (c.621+3A&gt;G) variant has been reported to have questionable pathogenicity, although its alleged severity was probably due to its co-segregation <jats:italic>in cis<\/jats:italic> with another undetected mutation, as previously reported from countries in the Mediterranean region. In the island of Cyprus, several rare <jats:italic>CFTR<\/jats:italic> variants have been previously identified, among them the c.489+3A&gt;G in co-segregation with the pathogenic p.Cys1400Ter (cDNA name\u2009=\u2009c.4200_4201del or legacy name\u2009=\u20094332delTG) mutation. We aimed to investigate the prevalence of these variants in Cyprus and describe their clinical impact in patients and carriers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The intronic variant c.489+3A&gt;G has been so far identified to co-segregate with the pathogenic p.Cys1400Ter mutation in the same allele in six unrelated Cypriot families and in total of 20 subjects. Three of them were diagnosed with CF, presenting with persistent respiratory symptoms, pancreatic insufficiency and a second CF-causing mutation. Two were diagnosed with CFTR-RD, presenting with bronchiectasis, intermediate sweat test and a second mutation known to cause CFTR-RD. Also, four carriers had a high suspicion of CFTR-RD, with bronchiectasis or emphysema and intermediate sweat test, although due to the lack of another <jats:italic>CFTR<\/jats:italic> mutation and a second functional test, definite diagnosis has not been made. Haplotype analysis provided evidence of a common haplotype in all individuals with co-segregation of the c.489+3A&gt;G variant with p.Cys1400Ter mutation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The intronic c.489+3A&gt;G variant co-segregates extensively with p.Cys1400Ter in Cyprus as an ancestral combination due to a possible founder effect. Before providing genetic counselling to subjects identified through population screening to harbour the c.489+3A&gt;G variant, extensive analysis of <jats:italic>CFTR<\/jats:italic> including gene rearrangements should be performed to identify possible other mutations <jats:italic>in cis<\/jats:italic>, especially in Mediterranean countries where this complex allele is probably common. Further research is warranted to fully delineate the clinical implications of the <jats:italic>in cis<\/jats:italic> co-segregation of p.Cys1400Ter with c.489+3A&gt;G, even in the absence of pathogenic variants in the other <jats:italic>CFTR<\/jats:italic> allele.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03714-3","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:00:36Z","timestamp":1745938836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-segregation of the c.489+3A&gt;G variant with p.Cys1400Ter pathogenic CFTR mutation in Cyprus: prevalence and clinical implications"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-9285","authenticated-orcid":false,"given":"Panayiotis K.","family":"Yiallouros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinelopi","family":"Anagnostopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis","family":"Kouis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas \u039c.","family":"Matthaiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonia","family":"Adamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phivos","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantina","family":"Costi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas A.","family":"Phylactou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlos","family":"Fanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassos","family":"Neocleous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"3714_CR1","unstructured":"The Clinical and Functional TRanslation of CFTR (CFTR2); [Internet]. Available from: http:\/\/cftr2.org. Accessed 12 Dec 2024."},{"key":"3714_CR2","unstructured":"Zolin A, Orenti A, Jung A, van Rens J et al. ECFSPR Annual Report 2021 [Internet]. 2023. Available from: https:\/\/www.ecfs.eu\/sites\/default\/files\/Annual%20Report_2021_09Jun2023.pdf"},{"issue":"4","key":"3714_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jcf.2013.12.003","volume":"13","author":"K De Boeck","year":"2014","unstructured":"De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros. 2014;13(4):403\u20139.","journal-title":"J Cyst Fibros"},{"key":"3714_CR4","unstructured":"CFMD\/CFTR1 Team. Cystic Fibrosis Mutation Database [Internet]. Available from: http:\/\/www.genet.sickkids.on.ca\/cftr\/Home.html. Accessed 14 Dec 2024."},{"issue":"6","key":"3714_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00439-001-0631-0","volume":"109","author":"M Tzetis","year":"2001","unstructured":"Tzetis M, Efthymiadou A, Doudounakis S, Kanavakis E. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A\u2192G, 2751+2T\u2192A, 296+1G\u2192C, 1717\u20139T\u2192C-D565G) and one nonsense mutation (E822X) in the CFTR gene. Hum Genet. 2001;109(6):592\u2013601.","journal-title":"Hum Genet"},{"issue":"1","key":"3714_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/jhg.2009.115","volume":"55","author":"M Forzan","year":"2010","unstructured":"Forzan M, Salviati L, Pertegato V, Casarin A, Bruson A, Trevisson E, et al. Is CFTR 621+3 A>G a cystic fibrosis causing mutation? J Hum Genet. 2010;55(1):23\u20136.","journal-title":"J Hum Genet"},{"issue":"12","key":"3714_CR7","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.3390\/jcm9123853","volume":"9","author":"MV Esposito","year":"2020","unstructured":"Esposito MV, Aveta A, Comegna M, Cernera G, Iacotucci P, Carnovale V, et al. Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers. J Clin Med. 2020;9(12):3853.","journal-title":"J Clin Med"},{"issue":"1","key":"3714_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcf.2007.04.004","volume":"7","author":"O Loumi","year":"2008","unstructured":"Loumi O, Ferec C, Mercier B, Creff J, Fercot B, Denine R, et al. CFTR mutations in the Algerian population. J Cyst Fibros. 2008;7(1):54\u20139.","journal-title":"J Cyst Fibros"},{"issue":"10","key":"3714_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/humu.23276","volume":"38","author":"M Claustres","year":"2017","unstructured":"Claustres M, Th\u00e8ze C, Des Georges M, Baux D, Girodon E, Bienvenu T, et al. CFTR -France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants. Hum Mutat. 2017;38(10):1297\u2013315.","journal-title":"Hum Mutat"},{"issue":"1","key":"3714_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13023-021-02049-z","volume":"16","author":"PK Yiallouros","year":"2021","unstructured":"Yiallouros PK, Matthaiou A\u039c, Anagnostopoulou P, Kouis P, Libik M, Adamidi T, et al. Demographic characteristics, clinical and laboratory features, and the distribution of pathogenic variants in the CFTR gene in the Cypriot cystic fibrosis (CF) population demonstrate the utility of a national CF patient registry. Orphanet J Rare Dis. 2021;16(1):409.","journal-title":"Orphanet J Rare Dis"},{"key":"3714_CR11","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","volume":"10","author":"C Bombieri","year":"2011","unstructured":"Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10:S86-102.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"3714_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1542\/peds.23.3.545","volume":"23","author":"LE Gibson","year":"1959","unstructured":"Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959;23(3):545\u20139.","journal-title":"Pediatrics"},{"issue":"8","key":"3714_CR13","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70\u201388. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3714_CR14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"key":"3714_CR15","unstructured":"World Health Organisation. WHO AnthroPlus: Software for assessing growth of the world\u2019s children and adolescents [Internet]. Geneva; 2009. Available from: https:\/\/www.who.int\/tools\/growth-reference-data for-5to19-year"},{"issue":"1","key":"3714_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TWR Lee","year":"2003","unstructured":"Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;2(1):29\u201334.","journal-title":"J Cyst Fibros"},{"issue":"8","key":"3714_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ejhg.2012.244","volume":"21","author":"Z Deans","year":"2013","unstructured":"Deans Z, Fiorentino F, Biricik A, Traeger-Synodinos J, Moutou C, De Rycke M, et al. The experience of 3 years of external quality assessment of preimplantation genetic diagnosis for cystic fibrosis. Eur J Hum Genet. 2013;21(8):800\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"S2","key":"3714_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ng0694supp-246","volume":"7","author":"G Gyapay","year":"1994","unstructured":"Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, et al. The 1993\u201394 G\u00e9n\u00e9thon human genetic linkage map. Nat Genet. 1994;7(S2):246\u2013339.","journal-title":"Nat Genet"},{"issue":"4","key":"3714_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/0888-7543(92)90071-Y","volume":"13","author":"N Morral","year":"1992","unstructured":"Morral N, Estivill X. Multiplex PCR amplification of three microsatellites within the CFTR gene. Genomics. 1992;13(4):1362\u20134.","journal-title":"Genomics"},{"issue":"6","key":"3714_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jcf.2023.06.001","volume":"22","author":"I Sadras","year":"2023","unstructured":"Sadras I, Kerem E, Livnat G, Sarouk I, Breuer O, Reiter J, et al. Clinical and functional efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis carrying the N1303K mutation. J Cyst Fibros. 2023;22(6):1062\u20139.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"3714_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/diagnostics11020168","volume":"11","author":"M Sterrantino","year":"2021","unstructured":"Sterrantino M, Fuso A, Pierandrei S, Bruno SM, Testino G, Cimino G, et al. Quantitative Evaluation of CFTR Pre-mRNA Splicing Dependent on the (TG)mTn Poly-Variant Tract. Diagnostics. 2021;11(2):168.","journal-title":"Diagnostics"},{"issue":"1","key":"3714_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2214\/ajr.173.1.10397098","volume":"173","author":"Y Cartier","year":"1999","unstructured":"Cartier Y, Kavanagh PV, Johkoh T, Mason AC, M\u00fcller NL. Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases. Am J Roentgenol. 1999;173(1):47\u201352.","journal-title":"Am J Roentgenol"},{"issue":"2","key":"3714_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2214\/ajr.165.2.7618537","volume":"165","author":"DB Reiff","year":"1995","unstructured":"Reiff DB, Wells AU, Carr DH, Cole PJ, Hansell DM. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am J Roentgenol. 1995;165(2):261\u20137.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"3714_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","volume":"21","author":"C Castellani","year":"2022","unstructured":"Castellani C, De Boeck K, De Wachter E, Sermet-Gaudelus I, Simmonds N, Southern K. ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria. J Cyst Fibros. 2022;21(6):908\u201321.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"3714_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jcf.2024.03.008","volume":"23","author":"NJ Simmonds","year":"2024","unstructured":"Simmonds NJ, Southern KW, De Wachter E, De Boeck K, Bodewes F, Mainz JG, et al. ECFS standards of care on CFTR-related disorders: Identification and care of the disorders. J Cyst Fibros. 2024;23(4):590\u2013602.","journal-title":"J Cyst Fibros"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03714-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03714-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03714-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:00:49Z","timestamp":1745938849000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03714-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3714"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03714-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Cyprus National Bioethics Committee (EEBK \u0395\u03a0 2017.01.117). A written informed consent was obtained from the probands or their legal guardians to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Probands provided family pedigrees, clinical data and gave written consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}